Abstract
President Obama announced the Precision Medicine Initiative in his 2015 State of the Union address, a research effort to find treatments that are tailored to specific genetic profiles and characteristics. This personalized and context-specific treatment approach will require big data analysis of patient outcomes and their genetic sequence, which must then be accessible and comprehensible to caregivers. The initiative must therefore be able to reconcile genetic data, demographic information, and health information, in the electronic health record. To achieve data interoperability, the organizations engaged in the initiative must confront questions of data privacy, standardize data exchange, and incentivize the adoption of data-sharing technology.
Files
Metadata
- Subject
Science and Technology Law
- Journal title
Boston College Intellectual Property and Technology Forum
- Volume
2017
- Pagination
1-15
- Date submitted
29 November 2022
- Related URL